Clinical trial
EValuation of Outcomes of Transcatheter Mitral Valve Repair for the Treatment of Low Ejection Fraction and Moderate Functional Mitral ValvE Regurgitation In Heart Failure
NCT03705312 is registered in ClinicalTrials.gov with Montreal Heart Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- EValuation of Outcomes of Transcatheter Mitral Valve Repair for the Treatment of Low Ejection Fraction and Moderate Functional Mitral ValvE Regurgitation In Heart Failure
- Lead sponsor
- Montreal Heart Institute
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- February 22, 2019
- Completion date
- January 31, 2022
- Enrollment
- 174 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
heart failure, mitral regurgitation, mitral valve regurgitation due to cardiomyopathy (disorder)